Genomics and the new perspectives for temporomandibular disorders

Archives of Oral Biology

Volumn 56, Issue 11, 2011, Pages 1181-1191

  Meloto, Carolina B ^a   Serrano, Priscila O ^a   Ribeiro Dasilva, Margarete C ^b   Rizzatti Barbosa, Célia M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Allelic variant; Genetic makers; Genome omics based personalised care; Polymorphisms; Temporomandibular disorder

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOL METHYLTRANSFERASE; ESTROGEN RECEPTOR; SEROTONIN TRANSPORTER;

ALLELE; FACE PAIN; GENETIC POLYMORPHISM; GENETICS; GENOMICS; HUMAN; PERSONALIZED MEDICINE; REVIEW; TEMPOROMANDIBULAR JOINT DISORDER;

ALLELES; CATECHOL O-METHYLTRANSFERASE; FACIAL PAIN; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ESTROGEN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 80054992648     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2011.03.012     Document Type: Review

References (115)

1. C.S. Greene, and D.M. Laskin Temporomandibular disorders: moving from a dentally based to a medically based model J Dent Res 78 10 2000 1726 1729
2. J.P. Okeson Etiology of functional disturbances in the masticatory system Management of temporomandibular disorders and occlusion 2008 Mosby St. Louis p. 130-62
3. J.A. McNamara Jr., D.A. Seligman, and J.P. Okeson Occlusion, orthodontic treatment, and temporomandibular disorders: a review J Orofac Pain 9 1 1984 72 89
4. H. Koh, and P.G. Robinson Occlusal adjustment for treating and preventing temporomandibular joint disorders J Oral Rehab 31 4 2004 287 292 (Pubitemid 38591879)
5. G.L. Engel The need for a new medical model: a challenge for biomedicine Science 195 4285 1966 129 136
6. S.F. Dworkin, and D.L. Massoth Temporomandibular disorders and chronic pain: disease or illness? J Prosthet Dent 71 1 1983 29 38
7. A.R. Wright, R.J. Gatchel, L. Wildenstein, R. Riggs, P. Buschang, and E. Ellis III Biopsychosocial differences between high-risk and low risk patients with acute TMD-related pain J Am Dent Assoc 135 2004 473 482
8. T.I. Suvinen, P.C. Raede, P. Kemppainen, M. Könönen, and S.F. Dworkin Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors Eur J Pain 9 2005 613 633 (Pubitemid 41503558)
9. G.D. Klasser, and C.S. Greene The changing field of temporomandibular disorders: what dentists need to know J Can Dent Assoc 74 1 2009 49 53
10. H. Cohen, L. Neumann, Y. Glazer, R.P. Ebstein, and D. Buskila The relationship between a common catechol-o-methyltransferase (COMT) polymorphism val(158)met and fibromyalgia Clin Exp Rheumatol 27 2009 S51 S56
11. J.B. Matsuda, F.R. Barbosa, L.J. Morel, C. Frana Sde, S.M. Zingaretti, and L.M. da Silva Serotonin receptor (5-HT 2 A) and catechol-o-methyltransferase (COMT) gene polymorphisms:triggers or fibromyalgia? Rev Bras Reumatol 50 2010 141 149
12. B.K. Mishra, T. Wu, I. Belfer, C.A. Hodgkinson, L.G. Cohen, and C. Kiselycznyk Do motor control genes contribute to interindividual variability in decreased movement in patients with pain? Mol Pain 26 2007 3 20
13. Modic changes and interleukin 1 gene locus polymorphisms in occupational cohort of middle-aged men Eur Spine J 18 2009 1963 1970
14. T.M. Guo, M. Liu, Y.G. Zhang, W.T. Guo, and S.X. Wu Association between caspase-9 promoter region polymorphisms and discogenic low back pain Connect Tissue Res 22 2010 [Epub ahead of print]
15. A.F.J. Griffiths, W.M. Gelbart, R.C. Lewontin, and J.H. Miller Integrating genes and genomes Modern genetic analysis 2nd ed. 2002 W Freeman and Co. New York p. 589
16. K.G. Raphael, J.J. Marbach, R.M. Gallagher, and B.P. Dohrenwend Myofascial TMD does not run in families Pain 79 1999 15 22 (Pubitemid 29151685)
17. B.S. Michalowicz, B.L. Pihlstrom, J.S. Hodges, and T.J. Bouchard Jr. No heritability of temporomandibular joint signs and symptoms J Dent Res 78 2000 1572 1577
18. A. Heiberg, B. Heloe, A.R. Heiberg, L.A. Heloe, P. Magnus, and K. Berg Myofascial pain dysfunction (MPD) syndrome in twins Community Dent Oral Epidemiol 8 1980 434 436
19. G.D. Slade, L. Diatchenko, R. Ohrbach, and W. Maixner Orthodontic treatment, genetics and risk of temporomandibular disorder Semin Orth 14 2 2008 146 156
20. S.F. Dworkin, K.H. Huggins, L. LeResche, M. Von Korff, J. Howard, and E. Truelove Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls J Am Dent Assoc March 120 1979 272 280
21. J.P. Goulet, G.J. Lavigne, and J.P. Lund Jaw pain prevalence among French-speaking Canadians in Québec and related symptoms of temporomandibular disorders J Dent Res 73 1984 1728 1734
22. M. Kamisaka, H. Yatani, T. Kuboki, Y. Matsuka, and H. Minakuchi Four-year longitudinal course of TMD symptoms in an adult population and the estimation of risk factors in relation to symptoms J Orofac Pain 14 2000 224 232
23. D. Locker, and G. Slade Prevalence of symptoms associated with temporomandibular disorders in a Canadian population Community Dent Oral Epidemiol 16 1977 310 313
24. L. LeResche, K. Saunders, M.R. Von Korff, W. Barlow, and S.F. Dworkin Use of exogenous hormones and risk of temporomandibular disorder pain Pain 69 1997 153 160 (Pubitemid 27081421)
25. T.V. Macfarlane, A.S. Blinkhorn, R.M. Davies, J. Kincey, and H.V. Worthington Association between female hormonal factors and oro-facial pain: study in the community Pain 97 2002 5 10 (Pubitemid 34603304)
26. N. Landi, I. Lombardi, D. Manfredini, E. Casarosa, K. Biondi, and M. Gabannini Sexual hormone serum levels and temporomandibular disorders. A preliminary study Gynecol Endocrinol 20 2005 98 102
27. B.L. Langdahl, D. Lokke, M. Carstens, L.L. Stenkjaer, and E.F. Eriksen A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not J Bone Miner Res 15 2000 2222 2230
28. O.M.E. Albagha, F.E.A. McGuigan, D.M. Reid, and S.H. Rlston Estrogen receptor α gene polymorphism and bone mineral density: haplotype analysis in women from the United Kingdom J Bone Miner Res 16 2001 128 134 (Pubitemid 32046197)
29. L. Gennari, L. Becherini, L. Masi, R. Mansani, S. Gonnelli, and C. Cepollaro Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density J Clin Endocrinol Metab 82 1987 929 934
30. J.T. Ivanova, P.B. Doukova, M.A. Boyanov, and P.R. Popivanov PvuII and XbaI polymorphisms of the estrogen receptor gene and bone mineral density in a Bulgarian population sample Hormones (Athens) 6 2007 36 43
31. S. Kobayashi, S. Inoue, T. Hosoi, Y. Ouchi, M. Shiraki, and H. Orimo Association of bone mineral density with polymorphisms of the estrogen receptor gene in post-menopausal women J Bone Miner Res 11 1985 306 311
32. Y. Yamada, F. Ando, N. Niino, S. Ohta, and H. Shimokata Association of polymorphisms of the estrogen receptor α gene with bone mineral density of the femoral neck in elderly Japanese women J Mol Med 79 2002 452 459
33. A.P. Bergink, J.B. van Meurs, J. Loughlin, P.P. Arp, Y. Fang, and A. Hofman Estrogen receptor α gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women Arthr Rheum 48 2003 1903 1912
34. S.Y. Jin, S.J. Hong, H.I. Yang, S. Park, M.C. Yoo, and H.J. Lee Estrogen receptor α gene haplotype is associated with primary knee osteoarthritis in Korean population Arthr Res Ther 6 2004 415 421
35. Y. Koshizuka, N. Ogata, M. Shiraki, T. Hosoi, A. Seichi, and K. Takeshita Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women Eur J Spine 15 2006 1521 1528 (Pubitemid 44583665)
36. T. Ushiyama, H. Ueyama, K. Inoue, J. Nishioka, I. Ohkubo, and S. Hukuda Estrogen receptor gene polymorphism and generalized osteoarthritis J Rheumatol 25 1998 134 137 (Pubitemid 28060131)
37. T. Ushiyama, K. Mori, K. Inoue, J. Huang, J. Nishioka, and S. Hukuda Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis Ann Rheum Dis 58 1999 7 10 (Pubitemid 29112943)
38. S.C. Kang, D.G. Lee, J.H. Choi, S.T. Kim, Y.K. Kim, and H.J. Ahn Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients Int J Oral Maxillofac Surg 36 2007 390 393
39. M.C.R. Ribeiro-Dasilva, S.R.P. Line, M.C.L.G. Santos, M.T. Arthuri, W. Hou, and R.B. Fillingim Estrogen receptor-α polymorphism and predisposition to TMJ disorder J Pain 10 2009 527 533
40. S.F. Grant, D.M. Reid, G. Blake, R. Herd, I. Fogelman, and S.H. Ralston Reduced bone density and osteoporosis associated with a polymorphism Sp1 binding site in the collagen type 1 alpha 1 gene Nat Genet 14 1985 203 205
41. A.G. Uitterlinden, H. Burger, Q. Huang, F. Yue, F.E. McGuigan, and S.F. Grant Relation of alleles of the collagen type I alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women N Engl J Med 338 1987 1006 1021
42. D.M. Herrington, T.D. Howard, K.B. Brosnihan, D.P. McDonnel, X. Li, and G.A. Hawkins Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein Circulation 105 2002 1868 1871
43. S. Iwashita, K. Koyama, and Y. Nakamura VNTR sequence on human chromosome 11p15 that affects transcriptional activity J Hum Genet 46 2001 707 711
44. A.O. Abubaker, W.F. Raslan, and G.C. Sotereanos Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study J Oral Maxillofac Surg 51 1993 1095 1099
45. K. Yamada, K. Nozawa-Inoue, Y. Kawano, S. Kohno, N. Amizuka, and T. Iwanaga Expression of estrogen receptor alpha (ER alpha) in the rat temporomandibular joint Anat Rec A Discov Mol Cell Evol Biol 273 2003 924 931
46. M.C. Ng, R.P. Harper, C.T. Le, and B.S. Wong Effects of estrogen on condylar cartilage of the rat mandible in organ culture J Oral Maxillofac Surg 57 1989 808 813
47. K.I. Yun, C.H. Chae, and C.W. Lee Effect of estrogen on the expression of cytokines of the temporomandibular joint cartilage cells of the mouse J Oral Maxillofac Surg 65 2008 871 876
48. N. Galal, W.R. El-Beialy, Y. Deyama, Y. Yoshimura, K. Suzuki, and Y. Totsuka Novel effect of estrogen on RANK and c-fms expression in RAW 263.7 cells Int J Mol Med 20 2007 96 100
49. N. Galal, W.R. El-Beialy, Y. Deyama, Y. Yoshimura, T. Yoshikawa, and K. Suzuki Effect of estrogen on bone resorption and inflammation in the temporomandibular joint cellular elements Int J Mol Med 21 2008 775 779
50. S. Kuroda, K. Tanimoto, T. Izawa, S. Fujihara, J.H. Koolstra, and E. Tanaka Biomechanical and biochemical characteristics of the mandibular condylar cartilage Osteoarth Cartil 17 2009 1408 1415
51. D. Manfredini, F. Piccotti, G. Ferronato, and L. Guarda-Nardini Age peaks of different RDC/TMD diagnoses in a patient population J Dent 38 2010 392 399
52. L. LeResche, L. Mancl, J.J. Sherman, B. Gandara, and S.F. Dworkin Changes in temporomandibular disorder and other symptoms across the menstrual cycle Pain 106 2003 253 261 (Pubitemid 37505873)
53. V. Puri, S. Chandrala, S. Puri, C.G. Daniel, R.M. Klein, and N.E.J. Berman Ghrelin in expressed in trigeminal neurons of female mice in phase with the estrous cycle Neuropeptides 40 2006 35 46 (Pubitemid 43255411)
54. D.A. Bereiter Sex differences in brainstem neural activation after injury to the TMJ region Cells Tissues Organs 169 2001 226 237 (Pubitemid 32656649)
55. N.M. Flake, D.B. Bonebreak, and M.S. Gold Estrogen and inflammation increase the excitability of rat temporomandibular joint afferent neurons J Neurophysiol 93 2005 1585 1597 (Pubitemid 40283742)
56. X.-D. Dong, M.K. Mann, U. Kumar, P. Svensson, L. Arendt-Nielsen, and J.W. Hu Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity Neuroscience 146 2007 822 832 (Pubitemid 46617063)
57. J.A. McRoberts, J. Li, H.S. Ennes, and E.A. Mayer Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons Neuroscience 148 2007 1015 1020 (Pubitemid 47422390)
58. J.S. Mogil The genetic mediation of individual differences in sensitivity to pain and its inhibition Proc Natl Acad Sci USA 95 1989 7634 7641
59. J.J. Marbach, and M. Levitt Erythrocyte catechol-O-methyltransferase activity in facial pain patients J Dent Res 55 1965 701
60. P.T. Mannisto, and S. Kaakkola Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol Rev 51 1999 593 628
61. 3-adrenergic receptors Pain 128 2007 198 208
62. T. Xie, S.L. Ho, and D. Ramsden Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription Mol Pharmacol 56 1989 31 38
63. S. Shifman, M. Bronstein, M. Sternfeld, A. Pisante-Shalom, E. Lev-Lehman, and A. Weizman A highly significant association between a COMT haplotype and schizophrenia Am J Hum Genet 70 2002 1295 1302
64. L. Diatchenko, G.D. Slade, A.G. Nackley, K. Bhalang, A. Sigurdsson, and I. Belfer Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum Mol Gen 14 1 2005 135 143 (Pubitemid 40123469)
65. G.D. Slade, L. Diatchenko, K. Bhalang, A. Sigurdsson, R.B. Fillingim, and I. Belfer Influence of psychological factors on risk of temporomandibular disorders J Dent Res 86 2007 1120 1125
66. D.J. Torpy, D.A. Papanicolaou, A.J. Lotsikas, R.L. Wilder, G.P. Chrousos, and S.R. Pillemer Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia Arthritis Rheum 43 2000 861 879
67. H. Steiner, and C.R. Gerfen Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior Exp Brain Res 123 1-2 1987 59 75
68. J.K. Zubieta, M.M. Heitzeg, Y.R. Smith, J.A. Bueller, K. Xu, and Y. Xu COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor Science 298 2003 1240 1243 (Pubitemid 36237467)
69. K.B. Jensen, T.B. Lonsdorf, M. Schalling, E. Kosek, and M. Ingvar Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val158met polymorphism Pain Treat Gen 4 6 2009 1 5
70. K. Light, E.E. Bragdon, K.M. Grewen, K.A. Brownley, S.S. Girdler, and W. Maixner Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder J Pain 10 5 2009 542 552
71. C. Sanchez, and J. Hyttel Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding Cell Mol Neurobiol 19 1989 466 488
72. J.D. Levine, Y.O. Taiwo, S.D. Collins, and J.K. Tam Noradrenalin hyperalgesia is mediated through interaction with sympathetic postganglionic neuron terminals rather than activation of primary afferent nociceptors Nature 323 5973 1975 158 159
73. M. Nakamura, and S.H. Ferreira A peripheral sympathetic component in inflammatory hyperalgesia Eur J Pharmacol 135 2 1976 145 153
74. L.E. Ta, and R.A. Dionne Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen Pain 111 1-2 2004 13 21 (Pubitemid 39141002)
75. A. Pelegrini-da-Silva, M.C.G. Oliveira, C.A. Parada, and C.H. Tambeli Nerve growth factor acts with β2-adrenoceptor to induce spontaneous nociceptive behavior during temporomandibular joint inflammatory hyperalgesia Life Sci 82 2008 770 775
76. J.J. Mann, R.P. Brown, J.P. Halper, J.A. Sweeney, J.H. Kocsis, and P.E. Stokes Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation N Engl J Med 313 1974 705 710
77. J.R. Magliozzi, D. Gietzen, R.J. Maddock, D. Haack, A.R. Doran, and T. Goodman Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls Biol Psychiatry 26 1978 15 25
78. B.H. Yu, J.E. Dimsdale, and P.J. Mills Psychological states and lymphocyte beta-adrenergic receptor responsiveness Neuropsychopharmacology 21 1989 147 152
79. K. Hagen, J.A. Zwart, J. Holmen, S. Svebak, G. Bovim, and L.J. Stovner Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study Arch Intern Med 164 2005 906 912
80. A.L. Parola, and B.K. Kobilka The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis J Biol Chem 268 1983 4496 4505
81. I. Belfer, B. Buzas, C. Evans, H. Hipp, G. Phillips, and J. Taubman Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans Eur J Hum Genet 13 3 2005 341 351 (Pubitemid 40360790)
82. L. Diatchenko, A.D. Anderson, G.D. Slade, R.B. Fillingim, S.A. Shabalina, and T. Higgins Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and risk for development of a common musculoskeletal pain disorder Am J Med Gen Neuropsychiatr Gent 141B 5 2006 449 461
83. K.M. Small, D.W. McGraw, and S.B. Liggett Pharmacology and physiology of human adrenergic receptor polymorphisms Annu Rev Pharmacol Toxicol 43 2003 380 411
84. N. Praschak-Rieder, M. Willeit, D. Winkler, A. Neumeister, E. Hilger, and P. Zill Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder Eur Neuropsychopharmacol 12 2002 129 134 (Pubitemid 34168477)
85. M. Narita, N. Nishigami, N. Narita, K. Yamaguti, N. Okado, and Y. Watanabe Association between serotonin transporter gene polymorphism and chronic fatigue syndrome Biochem Biophys Res Commun 311 2003 263 265
86. M.B. Yunus Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain Best Pract Res Clin Rheumatol 21 2007 480 496
87. J.D. Kranzler, J.F. Gendreau, and S.G. Rao The psychopharmacology of fibromyalgia: a drug development perspective Psychopharmacol Bull 36 2002 164 213
88. K.P. Lesch, D. Bengel, A. Heils, S.Z. Sabol, B.D. Greenberg, and S. Petri Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 273 1985 1527 1531
89. D.A. Collier, M.J. Arranz, T. Li, D. Mupita, N. Brown, and J. Treasure Association between 5-HT2A gene promoter polymorphism and anorexia nervosa Lancet 350 1986 412
90. H. Kunugi, M. Hattori, T. Kato, M. Tatsumi, T. Sakai, and T. Sasaki Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder Mol Psychiatry 2 1986 457 461
91. A. Anastassaki, and T. Magnusson Patients referred to a specialist clinic because of suspected temporomandibular disorders: a survey of 3193 patients in respect of diagnoses, treatments, and treatment outcome Acta Odontol Scand 61 2004 182 191
92. I. Meira-Lima, L. Michelon, Q. Cordeiro, H.J. Cho, and H. Vallada Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder J Mol Neurosci 27 2005 219 224 (Pubitemid 41356403)
93. D. Hranilovic, J. Stefulj, S. Schwab, M. Borrmann-Hassenbach, M. Albus, and B. Jernej Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression Biol Psychiatry 55 2004 1089 1093
94. B.D. Greenberg, T.J. Tolliver, S.J. Huang, Q. Li, D. Bengel, and D.L. Murphy Genetic variation in the serotonin transporter region affects serotonin uptake in human blood platelets Am J Med Genet (Neuropsychiatr Genet) 87 1989 82 86
95. A. MacKenzie, and J. Quinn A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo Proc Natl Acad Sci USA 95 1989 15251 15255
96. K. Ojima, N. Watanabe, N. Narita, and M. Narita Temporomandibular disorder is associated with a serotonin transporter gene polymorphism in the Japanese population Biopsychosocial Med 1 2007 3
97. P.J. Mease Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors Am J Med 122 2009 S44 S55
98. L.M. Arnold, Y. Lu, and L.J. Crofford A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arthritis Rheum 50 2004 2963 2973
99. L.M. Arnold, A. Rosen, Y.L. Pritchett, D.N. D'Souza, D.J. Goldstein, and S. Ivengar A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder Pain 119 2005 5 15 (Pubitemid 41752960)
100. R.M. Gendreau, M.D. Thorn, J.F. Gendreau, J.D. Kranzler, S. Ribeiro, and R.H. Gracely Efficacy of milnacipran in patients with fibromyalgia J Rheumatol 32 2005 1964 1974
101. D.J. Clauw, P. Mease, R.H. Palmer, R.M. Gendreau, and Y. Wang Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial Clin Ther 30 2008 1977 2004
102. I.J. Russell, P.J. Mease, T.R. Smith, D.K. Kajdasz, M.M. Wohlreich, and M.J. Detke Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial Pain 136 2008 432 444
103. J.P. Mease, D.J. Clauw, R.M. Gendreau, S.G. Rao, J. Kranzler, and W. Chen The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial J Rheumatol 36 2009 388 409
104. D. Mochizucki Serotonin and noradrenaline reuptake inhibitors in animal models of pain Hum Psychopharmacol 19 suppl 1 2004 S15 S19
105. C.K. Jones, B.J. Eastwood, A.B. Need, and H.E. Shannon Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition Neuropharmacology 51 2006 1171 1179
106. A. Toyofuku, and H. Miyako A case of temporomandibular disorder with fibromyalgia treated with the antidepressant, milnacipran Hum Psychopharmacol 19 2004 357 358 (Pubitemid 39106880)
107. J.L. Fackler, and A.L. McGuire Paving the way to personalized genomic medicine: steps to successful implementation Curr Pharmacogenomics Person Med 7 2009 125 10.2174/187569209788653998
108. E.P. Hoffman Skipping toward personalized molecular medicine N Engl J Med 357 2007 2719 2722
109. M.R. Trusheim, E.R. Berndt, and F.L. Douglas Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers Nat Rev Drug Discov 6 2007 287 293 (Pubitemid 46505879)
110. Vanier V. National physician group MDVIP partners with Navigenics. The Navigator [accessed 23.08.10].
111. W.G. Feero, A.E. Guttmacher, and F.S. Collins The genome gets personal - almost JAMA 299 2008 1351 1352 (Pubitemid 351439081)
112. A. McGuire, and W. Burke An unwelcome side effect of direct-to-consumer personal genome testing JAMA 300 2008 2669 2671
113. M.J. Khoury, M. Gwinn, P.W. Yoon, N. Dowling, C.A. Moore, and L. Bradley The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 9 2007 665 674 (Pubitemid 350287151)
114. R. Conti, D.L. Veenstra, K. Armstrong, L.J. Lesko, and S.D. Grosse Personalizad medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities Med Decis Making 30 2010 328 340
115. A.M. Gonzales-Angulo, B.T.J. Hennessy, and G.B. Mills Future of personalized medicine: a systems biology approach J Clin Oncol 28 2010 2777 2783